<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02059746</url>
  </required_header>
  <id_info>
    <org_study_id>AOI/2013/RdeT</org_study_id>
    <secondary_id>EGY/TDG/AR141876</secondary_id>
    <nct_id>NCT02059746</nct_id>
  </id_info>
  <brief_title>Perineal Consequences of Twin Pregnancies According to Mode of Delivery</brief_title>
  <acronym>JUMODA-CP</acronym>
  <official_title>Perineal Consequences of Twin Pregnancies According to Mode of Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an ancillary study to the &quot;JUMODA&quot; (National Prospective and Comparative Study on the
      Mode of Delivery of Twins) study: please see NCT01987063.

      The main objective of this study is to investigate the role of the mode of delivery (vaginal
      versus cesarean) as a risk factor for the occurrence of urinary incontinence at 3 months
      post-delivery in primiparous women delivering twins after 34 weeks of pregnancy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The secondary objectives of this study are to compare the following elements between
      primiparous mothers giving birth to twins vaginally versus by caesarean section after 34
      weeks of pregnancy (comparisons will be made at 3 months ant at 12 months post-partum):

      A. Diagnosis, type and severity of urinary incontinence via the ICIQ-UI questionnaire

      B. Urinary, anorectal and perineal symptoms via the PFDI-20 questionnaire

      C. Quality of life related to urinary, anorectal and pelvic floor symptoms via the PFIQ-7
      questionnaire

      D. Sexuality via the PISQ-12 questionnaire

      E. General quality of life via the SF-12 questionnaire
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence/absence of urinary incontinence</measure>
    <time_frame>3 months post-partum</time_frame>
    <description>Defined by a response of 1 to 5 on the first question of the ICIQ-UI questionnaire.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The ICIQ-UI questionnaire</measure>
    <time_frame>3 months post-partum</time_frame>
    <description>ICIQ-Urinary Incontinence Form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The PFDI-20 questionnaire</measure>
    <time_frame>3 months post-partum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The ICIQ-UI questionnaire</measure>
    <time_frame>12 months post-partum</time_frame>
    <description>ICIQ-Urinary Incontinence Form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The PFDI-20 questionnaire</measure>
    <time_frame>12 months post-partum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The PFIQ-7 questionnaire</measure>
    <time_frame>3 months post-partum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The PFIQ-7 questionnaire</measure>
    <time_frame>12 months post-partum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The PISQ-12 questionnaire</measure>
    <time_frame>3 months post-partum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The PISQ-12 questionnaire</measure>
    <time_frame>12 months post-partum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The SF-12 questionnaire</measure>
    <time_frame>3 months post-partum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The SF-12 questionnaire</measure>
    <time_frame>12 months post-partum</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">3039</enrollment>
  <condition>Pregnancy, Multiple</condition>
  <arm_group>
    <arm_group_label>Vaginal birth</arm_group_label>
    <description>Patients in the group give birth vaginally.
Intervention: Questionnaires sent by mail</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cesaren section</arm_group_label>
    <description>Patients in this group give birth via cesarean section.
Intervention: Questionnaires sent by mail</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires sent by mail</intervention_name>
    <description>The questionnaires necessary for the study are mailed to patients at 3 and 12 months post-partum.</description>
    <arm_group_label>Vaginal birth</arm_group_label>
    <arm_group_label>Cesaren section</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This is an ancillary to the &quot;JUMODA&quot; study (please see NCT01987063). The study population
        is composed of primiparous women pregnant with twins (non primiparous patients in the study
        JUMODA will therefore not includable), giving birth after 34 weeks to 2 live children.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient must have given his/her informed and signed consent

          -  The patient must be insured or beneficiary of a health insurance plan

          -  The patient is available for 12 months of follow-up following delivery

          -  The patient was included in the JUMODA study

          -  Primiparous

          -  Birth of 2 live children after 34 weeks of pregnancy

        Exclusion Criteria:

          -  Adult patient under guardianship

          -  Patient under judicial protection

          -  It proves impossible to correctly inform the patient

          -  Birth occurring before 34 weeks of pregnancy

          -  Birth not resulting in 2 living children
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Renaud de Tayrac, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHRU de Montpellier - Hôpital Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 9</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2014</study_first_submitted>
  <study_first_submitted_qc>February 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2014</study_first_posted>
  <last_update_submitted>April 5, 2016</last_update_submitted>
  <last_update_submitted_qc>April 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cesarean section</keyword>
  <keyword>vaginal birth</keyword>
  <keyword>twins</keyword>
  <keyword>urinary incontinence</keyword>
  <keyword>sexuality</keyword>
  <keyword>quality of life</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

